Glytone acne treatment flesh tinted acne (Genesis Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Glytone acne treatment flesh tinted acne drug offered from Genesis Pharmaceutical, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genesis Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | sulfur, resorcinol |
SUBSTANCE NAME: | RESORCINOL; SULFUR |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2010-05-25 |
END MARKETING DATE: | 2018-01-16 |
Glytone acne treatment flesh tinted acne HUMAN OTC DRUG Details:
Item Description | Glytone acne treatment flesh tinted acne from Genesis Pharmaceutical, Inc. |
LABELER NAME: | Genesis Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 80(mg/mL; mg/mL) |
START MARKETING DATE: | 2010-05-25 |
END MARKETING DATE: | 2018-01-16 |
PRODUCT ID: | 64760-081_ffa36fef-3698-4b9a-8b95-83b5f36ffda9 |
PRODUCT NDC: | 64760-081 |
APPLICATION NUMBER: | part333D |
Other RESORCINOL; SULFUR Pharmaceutical Manufacturers / Labelers: